TRANSFORMING FRACTURE RISK
ASSESSMENT FOR CANCER PATIENTS
WITH VERTEBRAL METASTASES
Computer-aided effective fracture risk stratification of patients with vertebral metastases for personalised treatment through robust computational models validated in clinical settings

Medical Professionals

Interview with Prof. Enrico Dall'Ara: AI and Biomechanics in METASTRA

For patients with vertebral metastases, assessing fracture risk in "undetermined" cases is a significant clinical challenge. Professor Enrico Dall'Ara introduces METASTRA's innovative three-level decision support system, designed to bring new clarity. Learn how this system integrates the SINS score with powerful AI and subject-specific biomechanical models to help clinicians stratify patients and assess risk with greater confidence.

Watch the video to see how this tool could shape the future of treatment planning.

Interview with Dr. Giovanni Barbanti Brodano: Improving surgical decisions

When does a vertebral metastasis require surgical intervention? Dr. Giovanni Barbanti Brodano, a spine surgeon at Istituto Ortopedico Rizzoli, shares the clinical challenges that drive the METASTRA project. Learn about "Train-METASTRA," the ambitious retrospective study of 2,000 patients designed to build a model that can help clinicians better calculate fracture risk and avoid unnecessary surgeries.

Interview with Dr. Aron Lazary: Developing reliable computational tools

A new tool is only effective if it can be seamlessly integrated into daily clinical practice. Dr. Aron Lazary, a spine surgeon and principal investigator, discusses the critical challenge of validating and implementing decision support tools. Learn why real-world patient data is essential for building trust and how the METASTRA project aims to create tools that are not only accurate but also practical for busy surgeons.